Biomarkers are transforming longevity science, offering a way to validate interventions, track biological aging, and shape future healthcare policies. In this interview, Martin O’Dea discusses the latest advancements in biomarker science, the role of AI-driven diagnostics, and the path toward regulatory acceptance. Watch now to explore the future of aging research.